Zurueck zur Suche

Reporte zur Charge UT7108MA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

12Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
KY 12

VAERS 1813103

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7108MA

gering
Staat
KY
Alter
70,0
Geschlecht
M
Eingang
23.10.2021
Impfdatum
15.10.2021
Beginn
15.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

this information is regarding the twelfth of 12 patients that received expired FLUZONE QIV NP with no reported adverse event; Initial information was received on 15-Oct-2021 regarding an unsolicited valid non-serious case received by nurse via other healthcare professional via physician (under Agency Inquiry Number-00814579). This case involves a 70 years old male patient who reported this information is regarding the twelfth of 12 patients that received expired fluzone qiv np with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were unknown. On 15-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UT7108MA, expiry- 30-jun-2021) via intramuscular route in unknown administration site. On 15-OCT-2021 the patient reported a this information is regarding the twelfth of 12 patients that received expired fluzone qiv np with no reported adverse event (expired product administered) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. It was reported "Nurse practitioner states that 12 patients have received FLUZONE QIV NP vaccines in her practice from 14OCT2021 to 15OCT2021 that expired on 30JUN2021. Caller asked how to proceed in this situation. Caller asked if there were any differences between the 2020 FLUZONE QIV NP vaccine and the 2021 FLUZONE QIV NP vaccine. See inquiries associated with this contact for additional patient information." Relevant lab data was not reported. Action taken with QUADRIVALENT INFLUENZA VACCINE was not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813102

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7108MA

gering
Staat
KY
Alter
62,0
Geschlecht
F
Eingang
23.10.2021
Impfdatum
15.10.2021
Beginn
15.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient received expired FLUZONE QIV with no reported adverse event; Initial information received on 15-Oct-2021 regarding an unsolicited valid non-serious case from a nurse practitioner via non health care professional/ consumer via physician via regulatory authority (under reference number 00814573). This case is linked to cases 2021SA345624, 2021SA344107, 2021SA345249, 2021SA345067, 2021SA345086, 2021SA344898, 2021SA345823, 2021SA345617 , 2021SA345419, 2021SA345587 and 2021SA345099 (same reporter). This case involves a 62 years old female patient who received an expired INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] (expired product administered). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. No concomitant medication and additional medications was given to patient. On 15-Oct-2021, the patient received a 0.5 ml first dose of 2021 of suspect INFLUENZA QUADRIVAL A-B VACCINE (once, lot UT7108MA and expiration date: 30-Jun-2021) via intramuscular route in the left deltoid for prophylactic vaccination. It was a case of an actual medication error due to expired vaccine used (same day latency). It was reported "Nurse practitioner states that 12 patients have received FLUZONE QIV NP vaccines in her practice from 14OCT2021 to 15OCT2021 that expired on 30JUN2021. Caller asked how to proceed in this situation. Caller asked if there were any differences between the 2020 FLUZONE QIV NP vaccine and the 2021 FLUZONE QIV NP vaccine." At time of reporting, no adverse event was reported and the outcome was unknown for the reported event (non-clinical). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813101

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7108MA

gering
Staat
KY
Alter
18,0
Geschlecht
F
Eingang
23.10.2021
Impfdatum
14.10.2021
Beginn
15.10.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

patients received expired FLUZONE QIV NP with no reported adverse event; Initial information received on 15-Oct-2021 regarding an unsolicited valid non-serious case received from a other health professional via Agency (under the reference 00814567). This case involves a 18 years old female patient who received expired INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] (expired product administered). The patient's medical history, medical treatment(s), concomitant medication(s) and family history were not provided. Patient had no other vaccines. On 14-Oct-2021, the patient received a dose of suspect FLUZONE QIV (0.5 ml, lot UT7108MA and expiration date: 30-Jun-2021) via intramuscular route in the left deltoid for prophylactic vaccination. It was an actual medication error due to expired vaccine used (same day latency). It was reported "Nurse practitioner states that 12 patients have received FLUZONE QIV NP vaccines in her practice from 14-OCT-2021 to 15-OCT-2021 that expired on 30-JUN-2021.Caller asked how to proceed in this situation. Caller asked if there were any differences between the 2020 FLUZONE QIV NP vaccine and the 2021 FLUZONE QIV NP vaccine." At time of reporting, the outcome was unknown for the reported event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813100

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7108MA

gering
Staat
KY
Alter
48,0
Geschlecht
F
Eingang
23.10.2021
Impfdatum
14.10.2021
Beginn
14.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

received expired FLUZONE QIV NP with no reported adverse event; Initial information received on 15-Oct-2021 regarding an unsolicited valid non-serious case received from an other health professional via Agency (under the reference 00814563). This case is linked to cases 2021SA344343, 2021SA344107, 2021SA345249, 2021SA345624, 2021SA345587, 2021SA344898, 2021SA345067, 2021SA345099, 2021SA345086, 2021SA345823 and 2021SA345419 (same reporter). This case involves a 48 years old female patient who received expired INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] (expired product administered). The patient's past medical history, medical treatment(s), concomitant medication(s) and family history were not provided. Patient had no other vaccines. On 14-Oct-2021, the patient received a dose of suspect FLUZONE QIV (0.5 ml, total, once, lot UT7108MA and expiration date: 30-Jun-2021) via intramuscular route in the left deltoid for prophylactic vaccination. It was an actual medication error due to expired product administered (same day latency). No adverse event was reported. It was reported "Nurse practitioner states that 12 patients have received FLUZONE QIV NP vaccines in her practice from 14OCT2021 to 15OCT2021 that expired on 30JUN2021. Caller asked how to proceed in this situation. Caller asked if there were any differences between the 2020 FLUZONE QIV NP vaccine and the 2021 FLUZONE QIV NP vaccine." At time of reporting, the outcome was unknown for the reported event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813099

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7108MA

gering
Staat
KY
Alter
10,0
Geschlecht
M
Eingang
23.10.2021
Impfdatum
14.10.2021
Beginn
14.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

patient received FLUZONE QIV NP from 14OCT2021 to 15OCT2021 that expired on 30JUN2021 with no AE; Initial information was received on 15-Oct-2021 regarding an unsolicited valid non-serious case from a nurse via regulatory authority (under reference: ). This case is linked to cases 2021SA344107, 2021SA344343, 2021SA344898, 2021SA345067, 2021SA345099, 2021SA345086, 2021SA345249, 2021SA345617,2021SA345624,2021SA345823,2021SA345419,2021SA345587(same reporter). This case involves a 10-year-old male patient who received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] on 14oct2021 that expired on 30-Jun-2021 (expired product administered). The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 14-Oct-2021, the patient received a first dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (0.5mL, once, total, lot UT7108MA, expiry date: 30-Jun-2021) via intramuscular route in the left deltoid for prophylactic vaccination. It was an actual case of medication error due to expired vaccine used (latency: same day). It was reported "Nurse practitioner states that 12 patients have received FLUZONE QIV NP vaccines in her practice from 14OCT2021 to 15OCT2021 that expired on 30JUN2021. Caller asked how to proceed in this situation. Caller asked if there were any differences between the 2020 FLUZONE QIV NP vaccine and the 2021 FLUZONE QIV NP vaccine. See inquiries associated with this contact for additional patient information. This information is regarding the seventh of 12 patients that received expired FLUZONE QIV NP." At time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813098

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7108MA

gering
Staat
KY
Alter
30,0
Geschlecht
F
Eingang
23.10.2021
Impfdatum
14.10.2021
Beginn
14.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

patient received FLUZONE QIV NP vaccine that expired on 30JUN2021 with no AE; Initial information was received on 15-Oct-2021 regarding an unsolicited valid non-serious case from a nurse via Agency (under reference:00814554). This case involves a 30-year-old female patient who received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] vaccine that expired on 30-Jun-2021 (expired product administered). The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 14-Oct-2021, the patient received a first dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (0.5mL, once, Total, lot UT7108MA, expiry date: 30-Jun-2021) via intramuscular route in the left deltoid for prophylactic vaccination. It was an actual case of medication error due to expired vaccine used (latency: same day). It was reported "Nurse practitioner states that 12 patients have received FLUZONE QIV NP vaccines in her practice from 14OCT2021 to 15OCT2021 that expired on 30JUN2021. Caller asked how to proceed in this situation. Caller asked if there were any differences between the 2020 FLUZONE QIV NP vaccine and the 2021 FLUZONE QIV NP vaccine. See inquiries associated with this contact for additional patient information. This information is regarding the seventh of 12 patients that received expired FLUZONE QIV NP." At time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813097

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7108MA

gering
Staat
KY
Alter
14,0
Geschlecht
F
Eingang
23.10.2021
Impfdatum
14.10.2021
Beginn
14.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Patient had received Fluzone QIV NP vaccines that expired on 30-Jun-2021 with no reported adverse event; Initial information received on 15-Oct-2021 regarding an unsolicited valid non-serious case received from a other health professional consumer non-healthcare professional via Agency number: 00814542 This case is linked to cases 2021SA344343, 2021SA344107 and 2021SA345249(CLUSTER). This case involves a 14 years old female patient who was administered an expired dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] (expired product administered). The patient's medical history, past medical treatments, vaccinations, concomitant medications and family history were not provided. On 14-Oct-2021, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number: UT7108MA and expiry number: 30-JUN-2021 via intramuscular route in unknown administration site prophylactic vaccination. It was case of an actual medication error due to expired vaccine used (latency: same day). At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813096

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7108MA

gering
Staat
KY
Alter
13,0
Geschlecht
F
Eingang
23.10.2021
Impfdatum
14.10.2021
Beginn
14.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

patients have received FLUZONE QIV NP vaccines that expired; Initial information received on 15-Oct-2021 regarding an unsolicited valid non-serious case received from an other health professional via AGency (under the reference 00814533). This case was linked to cases 2021SA344107, 2021SA345249, 2021SA345624, 2021SA344898, 2021SA345067, 2021SA345099, 2021SA345086, 2021SA345617, 2021SA345823, 2021SA345419 and 2021SA344343 (same reporter). This case involves a 13 years old female patient who received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] that expired (expired product administered). The patient's medical history, medical treatment(s), concomitant medication(s) and family history were not provided. Patient had no other vaccines. On 14-Oct-2021, the patient received a dose of suspect FLUZONE QUADRIVALENT (0.5 ml, once, lot UT7108MA and expiration date: 30-Jun-2022) via intramuscular route in the left deltoid for prophylactic vaccination It was an actual medication error due to expired vaccine used (same day latency). It was reported "Nurse practitioner states that 12 patients have received FLUZONE QIV NP vaccines in her practice from 14OCT2021 to 15OCT2021 that expired on 30JUN2021. Caller asked how to proceed in this situation. Caller asked if there were any differences between the 2020 FLUZONE QIV NP vaccine and the 2021 FLUZONE QIV NP vaccine." No adverse event was reported. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813095

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7108MA

gering
Staat
KY
Alter
-
Geschlecht
F
Eingang
23.10.2021
Impfdatum
14.10.2021
Beginn
14.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

received expired FLUZONE QIV NP with no reported adverse event; Initial information was received on 15-Oct-2021 regarding an unsolicited valid non-serious case received from other health professional and physician via (Medical Information- 00814531). This case involves a 13-year old female patient who was vaccinated with expired dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] (Expired product administered). The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. No other concomitant vaccines were not provided. On 14-Oct-2021, the patient received a first 0.5ml dose of expired suspect INFLUENZA QUADRIVAL A-B VACCINE (FLUZONE QIV) (lot number UT7108MA and expiry date 30-Jun-2022 was reported) via intramuscular route in the left deltoid for prophylactic vaccination. It was reported "if there were any differences between the 2020 FLUZONE QIV NP vaccine and the 2021 FLUZONE QIV NP vaccine. This information is regarding the fourth of 12 patients that received expired FLUZONE QIV NP." It was a case of an actual medication error due to expired vaccine used (latency was on same day). At the time of report, no adverse event reported. Event outcome was unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813094

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7108MA

gering
Staat
KY
Alter
14,0
Geschlecht
M
Eingang
23.10.2021
Impfdatum
14.10.2021
Beginn
14.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient received expired vaccine of FLUZONE QUADRIVALENT with no adverse event; Initial information was received on 15-Oct-2021 regarding an unsolicited valid non-serious case from a other health professional, physician, non-healthcare professional via regulatory authority (under reference: 00814513). This case is linked to cases 2021SA344343, 2021SA344107 and 2021SA345249 (CLUSTER). This case involves a 14 years old male patient who received expired vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (expired product administered). The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided. On 14-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (0.5mL, once, total, lot UT7108MA, expiry date: 30-Jun-2021) via intramuscular route in the left deltoid for prophylactic vaccination. It was an actual case of medication error due to expired vaccine used (latency: same day). It was reported "Nurse practitioner states that 12 patients have received FLUZONE QIV NP vaccines in her practice from 14OCT2021 to 15OCT2021 that expired on 30JUN2021. Caller asked how to proceed in this situation. Caller asked if there were any differences between the 2020 FLUZONE QIV NP vaccine and the 2021 FLUZONE QIV NP vaccine." At time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813092

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7108MA

gering
Staat
KY
Alter
14,0
Geschlecht
M
Eingang
23.10.2021
Impfdatum
14.10.2021
Beginn
14.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient received expired vaccine of FLUZONE QUADRIVALENT with no adverse event; Initial information was received on 15-Oct-2021 regarding an unsolicited valid non-serious case from a other health professional, physician, non-healthcare professional via Media Information (under reference: 00814496). This case is linked to cases 2021SA344343, 2021SA344107 and 2021SA345249(CLUSTER). This case involves a 14 years old male patient who received expired vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (expired product administered). The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided. On 14-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (0.5mL, once, total, lot UT7108MA, expiry date: 30-Jun-2021) via an intramuscular route in the left deltoid for prophylactic vaccination. It was an actual case of medication error due to expired vaccine used (latency: same day). It was reported "Nurse practitioner states that 12 patients have received FLUZONE QIV NP vaccines in her practice from 14OCT2021 to 15OCT2021 that expired on 30JUN2021. Caller asked how to proceed in this situation. Caller asked if there were any differences between the 2020 FLUZONE QIV NP vaccine and the 2021 FLUZONE QIV NP vaccine." At time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813090

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7108MA

gering
Staat
KY
Alter
13,0
Geschlecht
M
Eingang
23.10.2021
Impfdatum
14.10.2021
Beginn
14.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Received expired Fluzone QIV with no reported adverse event; Initial information received on 15-Oct-2021 regarding an unsolicited valid non-serious case received from a other health professional and physician via regulatory authority number: 00814427. This case involves a 13 years old male patient who was administered an expired dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] (expired product administered). The patient's medical history, past medical treatments, vaccinations, concomitant medications and family history were not provided. On 14-Oct-2021, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UT7108MA and expiry date: 30-Jun-2021 via intramuscular route in unknown administration site prophylactic vaccination. It was case of an actual medication error due to expired vaccine used (latency: same day). At the time of reporting, no adverse event was reported. This suspected adverse reaction report was submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-